Study of Radiolabeled Danicopan in Healthy Male Participants
Status:
Completed
Trial end date:
2017-10-15
Target enrollment:
Participant gender:
Summary
This was an open-label study to evaluate the absorption, distribution, metabolism, and
excretion of radioactivity in healthy male participants following a single 150-milligram (mg)
oral dose of carbon-14 ([14C])-ACH-014447 ([14C])-danicopan) containing approximately 100
microcuries (µCi) of [14C].